The original rise of Sildenafil presented a significant opportunity for the market, but its patent has lapsed , creating a intricate landscape. Alternative versions have flooded the arena, diminishing https://emilybmkr521213.madmouseblog.com/22320487/the-little-blue-pill-and-pharma-a-risky-investment